Related Experiment Video
Updated: Aug 17, 2026
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Pediatric osteosarcoma: a 35-year experience in Slovenia
1Clinical Radiology Institute, University Medical Center Ljubljana, 1525 Ljubljana, Slovenia. dimitrij.kuhelj@guest.arnes.si
Insights
This study reviewed osteosarcoma treatment in Slovenian children and adolescents, finding a 48% survival rate. Chemotherapy and disease stage significantly impact survival, highlighting the need for new therapeutic strategies.
Area of Science:
- Pediatric Oncology
- Skeletal Oncology
- Medical Imaging
Background:
- Osteosarcoma is a primary bone cancer affecting children and adolescents.
- Long-term survival rates for osteosarcoma have historically been a challenge.
- Effective classification and prognostic factors are crucial for treatment planning.
Purpose of the Study:
- To review pediatric and adolescent osteosarcoma cases in Slovenia from 1968-1997.
- To evaluate a newly devised classification system for osteosarcoma.
- To identify prognostic factors influencing survival in young osteosarcoma patients.
Main Methods:
- Retrospective analysis of 74 patients diagnosed with osteosarcoma.
- Classification of patients using a novel system based on clinical and imaging data.
- Statistical analysis to determine prognostic factors affecting survival.
Main Results:
- Overall survival rate for the cohort was 48%.
- Disease stage at diagnosis and specific treatments, including chemotherapy, were significant prognostic factors.
- The newly developed classification system demonstrated adequacy in categorizing patients.
Conclusions:
- Chemotherapy has improved osteosarcoma survival rates in pediatric and adolescent populations.
- Further research into novel therapeutic strategies is warranted for various disease stages.
- The proposed clinical and imaging-based classification system is a valuable tool for osteosarcoma management.
Abstract:
The purpose of this study was to review all the children and adolescents treated for osteosarcoma in Slovenia between 1968 and 1997. Seventy-four patients were included in this retrospective study and classified according to the newly devised classification based on clinical and imaging studies. The overall survival rate is 48%. The stage of the disease and the treatment, including chemotherapy, are the only prognostic factors significantly influencing survival. The survival of patients with osteosarcoma has improved with chemotherapy, but new therapeutic strategies should be found for different stages of disease. The authors' newly devised classification based on clinical and imaging studies proved to be adequate.
